United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 22, 2026 · Filed Jul 23, 2026

On Jul 22, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$530.57 for US$5.04M under a trading plan, leaving 324,443 shares. Filed Jul 23, 2026 (Form 4).

Sold
9,500 shares
Price
US$530.57 average (US$524.27 to US$539.47)
Value
US$5.04M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 22, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Jul 22, 2026Common StockSale120US$524.27333,823Indirect
Jul 22, 2026Common StockSale485US$526.04333,338Indirect
Jul 22, 2026Common StockSale2,610US$526.84330,728Indirect
Jul 22, 2026Common StockSale1,211US$527.82329,517Indirect
Jul 22, 2026Common StockSale874US$528.91328,643Indirect
Jul 22, 2026Common StockSale760US$529.80327,883Indirect
Jul 22, 2026Common StockSale400US$531.22327,483Indirect
Jul 22, 2026Common StockSale489US$533.24326,994Indirect
Jul 22, 2026Common StockSale324US$534.19326,670Indirect
Jul 22, 2026Common StockSale107US$535.40326,563Indirect
Jul 22, 2026Common StockSale790US$536.49325,773Indirect
Jul 22, 2026Common StockSale570US$537.60325,203Indirect
Jul 22, 2026Common StockSale680US$538.46324,523Indirect
Jul 22, 2026Common StockSale80US$539.47324,443Indirect

Source

View original at SEC

Related